Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Lexi-Comp Inc. was a highly regarded provider of clinical drug information, pharmacogenomics data, and patient education resources tailored for healthcare professionals. Acquired by Wolters Kluwer Health in 2011, Lexi-Comp's comprehensive databases and decision support tools were integrated into Wolters Kluwer's Clinical Drug Information suite. These resources continue to uphold a legacy of accuracy and evidence-based content, empowering clinicians globally to make informed medical decisions and enhance patient safety at the point of care. Lexi-Comp's solutions have long been trusted for their depth and clinical relevance in various healthcare settings.
Historically, this facility served as the central hub for Lexi-Comp's research, content development, software engineering, and administrative operations for its suite of clinical information solutions.
The Hudson facility likely housed specialized departments for medical informatics, editorial teams for content creation and review, software development labs, and data management centers critical for maintaining extensive drug databases.
Lexi-Comp was recognized for fostering a work environment dedicated to precision, evidence-based practices, and innovation in clinical decision support. The culture was likely collaborative and mission-driven, focusing on improving healthcare outcomes and patient safety.
The Hudson headquarters was pivotal as the operational core where Lexi-Comp developed and maintained its industry-leading clinical databases and software tools, which became indispensable resources for numerous healthcare professionals and institutions worldwide.
Following its acquisition by Wolters Kluwer, Lexi-Comp's product offerings gained an expanded global reach. Wolters Kluwer Health leverages Lexi-Comp's foundational drug information and clinical content to serve healthcare professionals in over 180 countries. Globally supported functions include multilingual content delivery where appropriate, international sales and customer support, and integration of solutions with diverse healthcare information systems and regulatory standards worldwide.
1100 Terex Road
Hudson
Ohio
USA
Address: Wolters Kluwer Health, Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, USA
To serve as a key operational center for Wolters Kluwer Health in the United States, driving innovation, customer engagement, and market presence for its comprehensive suite of clinical decision support tools, including the Lexi-Comp branded solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Lexi-Comp Inc.' leadership includes:
Lexi-Comp Inc. has been backed by several prominent investors over the years, including:
Lexi-Comp Inc. was acquired by Wolters Kluwer in 2011 and does not operate as an independent entity with its own executive team. Therefore, there are no executive hires or exits specific to 'Lexi-Comp Inc.' in the last 12 months. Leadership changes relevant to Lexi-Comp product lines occur within the Wolters Kluwer Health organizational structure.
Discover the tools Lexi-Comp Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition by Wolters Kluwer, Lexi-Comp Inc. likely utilized standard corporate email formats such as [first_initial][last]@lexi.com or [first].[last]@lexi.com. Employees associated with Lexi-Comp products now use Wolters Kluwer's email system (e.g., firstname.lastname@wolterskluwer.com).
[first_initial][last]@lexi.com (historical estimate)
Format
jsmith@lexi.com (example of historical format)
Example
0%
Success rate
Wolters Kluwer News • February 13, 2024
Wolters Kluwer Health announced that its digital expert solutions, including the Lexicomp drug information solution, received high client satisfaction scores in the 2024 Best in KLAS: Software & Services report. This highlights clinicians' trust in these tools for informed decision-making and improved patient care....more
Wolters Kluwer News • June 7, 2023
Wolters Kluwer announced the launch of AI Labs, a new initiative to co-create generative AI solutions with customers. This initiative aims to enhance its expert solutions portfolio, which includes leading clinical decision support tools such as Lexicomp, by leveraging advanced AI capabilities to further support healthcare professionals....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Lexi-Comp Inc., are just a search away.